MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis
- DOI
- 10.1080/14796694.2026.2732579
- Published
- 2026-09-18
- Container
- Future Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2026.2732579,
title = {MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis},
author = {Jia-Yao Wang and Yan-Xiang Shao and Li-Li Yang and Hong-Shuai Li and Jia-Qi Liu and Rui-Zhi Liu and Shuang Zhang and Xiang Li and Ji-Yan Liu},
year = {2026},
journal = {Future Oncology},
doi = {10.1080/14796694.2026.2732579},
url = {https://doi.org/10.1080/14796694.2026.2732579}
}RIS
TY - JOUR TI - MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis AU - Jia-Yao Wang AU - Yan-Xiang Shao AU - Li-Li Yang AU - Hong-Shuai Li AU - Jia-Qi Liu AU - Rui-Zhi Liu AU - Shuang Zhang AU - Xiang Li AU - Ji-Yan Liu PY - 2026 JO - Future Oncology DO - 10.1080/14796694.2026.2732579 UR - https://doi.org/10.1080/14796694.2026.2732579 ER -
APA
Wang, J., Shao, Y., Yang, L., Li, H., Liu, J., Liu, R., Zhang, S., Li, X., & Liu, J. (2026). MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis. Future Oncology. https://doi.org/10.1080/14796694.2026.2732579
Source records
- crossref · retrieved 2026-09-26T04:00:14.874Z